1. Moderna

    0 Comments Leave a Comment

    1-15 of 25 1 2 »

    1. Mentioned In 25 Articles

    13. Question of The Week -- October 29, 2020

      Explore boardprospects.com Question of The Week
      Question of The Week -- October 29, 2020
      As outlined this past week by The Boston Globe, executives and board members at pharmaceutical companies involved in the development of Covid-19 vaccines have been amassing small fortunes during the past few months through the sale of stock they own in those companies -- benefiting from public speculation on the efficacy of such vaccines. Although legally, on its face, there is nothing wrong with such sales, is it time for the ...
      Read Full Article
      Mentions: Sale Pharmaceutical Companies Johnson & Johnson
    17. 1-15 of 25 1 2 »
  1. Search:

  2. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

  3. Related Topics

    1. Pronutria Adds Industry Leaders to its Board of Directors
      18 articles also mentioned CEO
    2. The Ex-Pharma Exec Leading Trump's COVID-19 Vaccine Program Has $10 Million in Stock Options for a Company Getting Federal Funding
      13 articles also mentioned COVID-19
    3. Moderna Appoints Israel Ruiz to Its Board of Directors
      11 articles also mentioned technology
    4. Dr. Elizabeth Nabel Joins Moderna Therapeutics' Board of Directors
      10 articles also mentioned AstraZeneca
    5. Stephen Berenson Joins Moderna's Board of Directors
      9 articles also mentioned Board

  4. Quotes about Moderna

    1. Upon meeting, the Board made the determination that it was appropriate to separate Mr Gomez from Moderna. Mr Gomez was immediately informed of that decision.
      In Moderna CFO’s Departure Reignites Debate Over Company’s Culture
    2. As Moderna approaches advanced stages of clinical development across our programs, we are focused on strengthening our board with industry leaders who understand the complexity of building companies to make a positive impact on patients.
      In Elizabeth Tallett Joins Moderna’s Board of Directors
    3. I am delighted to be joining Moderna's board at such a unique point in its history, as it rapidly moves towards commercialization of its first products and starts to fulfill its mission of creating a new class of life-saving mRNA medicines and vaccines.
      In Elizabeth Tallett Joins Moderna’s Board of Directors